findmyKOL
Clinical trialNCT00415038CompletedPhase 2Interventional

Efficacy of Rostafuroxin in the Treatment of Essential Hypertension

Sponsorsigma-tau i.f.r. S.p.A.Enrollment438Essential Hypertension
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Andrzej Tykarski, MD

    Department of hypertension - School of Medicine - Poznan (Poland)

    Principal Investigator
  • Andrzey Januszewicz, MD

    Department of Internal Medicine and Hypertension Warszawa (Poland)

    Principal Investigator
  • Antonio Coca-Payeras, MD

    Hospital Clinico de Barcelona - Barcelona (Spain)

    Principal Investigator
  • Antonio Pose-Reino, MD

    Hospital de Conxo - Santiago de Compostela (Spain)

    Principal Investigator
  • Bogdan Wyrzykowski, MD

    Department of Hypertension and Diabetology - Medical Academy - Gdansk (Poland)

    Principal Investigator
  • Carlos c Gomez, MD

    Hospital Clinico Universitario - Santiago de Compostela (Spain)

    Principal Investigator
  • Edoardo Casiglia, MD

    IV Clinica Medica dell'Università di Padova, Dipartimento di Medicina Clinica e Sperimentale - Padova (Italy)

    Study Director
  • Ezio Degli Esposti, MD

    Unità di valutazione dell'efficacia clinica - Direzione Aziendale Ospedale S. Maria delle Croci - Ravenna (Italy)

    Principal Investigator
  • Fernando Hernandez-Menarguez, MD

    Centro de la Salud de Vistalegre - La Flota, Murcia (Spain)

    Principal Investigator
  • Giancarlo Basso, MD

    U.O. Cardiologia - Ospedale Civile di Schio (Vicenza) Italy

    Principal Investigator
  • Gianni Bellomo, MD

    Dipartimento di Medicina Interna, Nefrologia e dialisi - Ospedale San Giovanni Battista - Foligno (Perugia) Italy

    Principal Investigator
  • Hilde Celis, MD

    Catholic University of Leuven Dept. of Molecular and cardiovascular Research, Laboratory of Hypertension

    Principal Investigator
  • James Barton, MD

    Portiuncola Hospital Cardiac Research Department - Ballinasloe co Galway (Ireland)

    Principal Investigator
  • Jan A Staessen, MD PhD

    Catholic University of Leuven, Laboratory of Hypertension Dept. of Molecular and cardiovascular Resesrach - Campus Gasthuisberg

    Study Chair
  • Jan Filipovsky, MD

    Derpartment of Internal Medicine 2, Faculty of Medicine - Pilsen (Czech Republic)

    Principal Investigator
  • Jose M Pascual-Izuel, MD

    Hospital de Sagunto - Sagunto (Valencia) - Spain

    Principal Investigator
  • Jose a Aleman, MD

    Centro de Salud Murcias San Andres - Murcia (Spain)

    Principal Investigator
  • Josep Redon, MD

    Hipertension Clinic, Hospital Clinico University of Valencia - Valencia (Spain)

    Principal Investigator
  • Kalina Kawecka-Jaszcz, MD

    Jagiellonian University Medical College Krakow - I Cardiac Department - Krakow (Poland)

    Principal Investigator
  • Marielle ME Krekels, MD

    Department of Medicine/Nephrology Maaslandziekenhuis - Sittard (The Netherlands)

    Principal Investigator
  • Michel Burnier, MD

    Division de Nephrologie, Department de Medecine, Centre Hopitalier Universitaire Vaudois - Lausanne (Switzerland)

    Principal Investigator
  • Miroslav Soucek, MD

    Department of Internal Medicine 2, St. Anne's Hospital, Faculty of Medicine - Brno (Czech Republic)

    Principal Investigator
  • Miroslaw Dluzniewski, MD

    Postgraduate Medical School - Department of cardiology - Warszawa (Poland)

    Principal Investigator
  • Nicola Glorioso, MD

    Centro per L'ipertensione A.S.L. n° 1 - Sassari (Italy)

    Principal Investigator
  • Paolo Manunta, MD

    Divisione di Nefrologia, Dialisi e Ipertensione - Ospedale S. Raffaele - Milano (Italy)

    Principal Investigator
  • Peter W De Leeuw, MD

    Academisch Ziekenhuis Maastricht Afdeling Nefrologie - Mastricht (The Netherlands)

    Principal Investigator
  • Rock Accetto, MD

    University Medical center, Hypertension Department - Ljubljana (Slovenia)

    Principal Investigator
  • Sergey Nedogoda, MD

    Department of Internal and family Medicine - Volgograd (Russia)

    Principal Investigator
  • Tomasz Grodzicki, MD

    Department of Internal Medicine and Gerontology - Jagiellonian University Medical College - Krakow (Poland)

    Principal Investigator
  • Viktor Milyagin, MD

    Department of Internal Medicine, Postgraduate Education Faculty Smolensk State medical Academy - Smolensk (Russia)

    Principal Investigator
  • Wieslawa Piwowarska, MD

    Coronary Disease Department - Jagiellonian University medical College - Krakow (Poland)

    Principal Investigator
  • Yuri Nikitin, MD

    Institute of internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences - Novosibirsk (Russia)

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Catholic University of Leuven - Laboratory of Hypertension, Dept. of Molecular and Cardiov. Research - Campus Gasthuisberg

    Leuven, Belgium

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2005
Primary completion
30 Apr 2007
Completion
31 Aug 2007
Last update posted
17 Jun 2011
Registered enrollment
438
Registry id
NCT00415038

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.